Edition:
United Kingdom

Manas Mishra

New $1 billion fund aims to steer antibiotic companies in tough market

09 Jul 2020

Several large drugmakers including Merck & Co Inc and Pfizer Inc on Thursday unveiled a $1 billion (790 million pounds) fund to bolster struggling antibiotic companies and sustain a pipeline for new treatments.

New $1 bln fund aims to steer antibiotic companies in tough market

09 Jul 2020

July 9 A new $1 billion fund backed by 20 drugmakers including Merck & Co Inc and Pfizer Inc is aiming to bolster struggling antibiotic companies and sustain a pipeline for new treatments, an industry group said on Thursday.

Aimmune says patients begin treatment with peanut allergy drug as COVID-19 lockdowns ease

02 Jul 2020

Aimmune Therapuetics Inc said its peanut allergy drug, whose launch had been paused because of coronavirus lockdowns, is again being administered to patients as allergy specialists reopen, the drugmaker's executives told Reuters on Thursday.

New drug launches stalled by COVID-19 pandemic

01 Jul 2020

The U.S. Food and Drug Administration has approved more than 30 new drugs since January. So far, five medicines have seen their commercial launches delayed by manufacturers until later in the year or 2021 because of the COVID-19 pandemic.

From Parkinson's to peanut allergy, pandemic puts brakes on new drugs

01 Jul 2020

Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters review of filings and interviews with executives show.

Inovio's COVID-19 vaccine candidate shows promise in small early-stage trial

30 Jun 2020

An experimental coronavirus vaccine developed by Inovio Pharmaceuticals Inc showed promise and was found to be safe in an early-stage human trial, the company said on Tuesday.

UPDATE 3-Vaxart says potential COVID-19 vaccine picked for 'Operation Warp Speed'

26 Jun 2020

June 26 Vaxart Inc said on Friday it would test its experimental oral COVID-19 vaccine on monkeys infected with the new coronavirus in a study funded by the Trump administration's vaccine-acceleration program called "Operation Warp Speed".

Sanofi clinches $2 billion vaccines deal with Translate Bio

23 Jun 2020

PARIS French drugmaker Sanofi has agreed a potential $2 billion (£1.6 billion) vaccines deal with Translate Bio , expanding their collaboration in development of an inoculation against COVID-19 and sending the U.S. biotech company's shares soaring.

World News